Abstract:<p>In rodents and humans, the major cellular events at spermatogenesis include self-renewal of spermatogonial stem cells and undifferentiated spermatogonia via mitosis, commitment of spermatogonia to differentiation and transformation to spermatocytes, meiosis, spermiogenesis, and the release of spermatozoa at spermiation. While details of the morphological changes during these cellular events have been delineated, knowledge gap exists between the morphological changes in the seminiferous epithelium and the underlying molecular mechanism(s) that regulate these cellular events. Even though many of the regulatory proteins and biomolecules that modulate spermatogenesis are known based on studies using genetic models, the underlying regulatory mechanism(s), in particular signaling pathways/proteins, remain unexplored since much of the information regarding the signaling regulation is unknown. Studies in the past decade, however, have unequivocally demonstrated that the testis is using several signaling proteins and/or pathways to regulate multiple cellular events to modulate spermatogenesis. These include mTORC1/rpS6/Akt1/2 and p-FAK-Y407. While selective inhibitors and/or agonists and antagonists are available to examine some of these signaling proteins, their use have limitations due to their specificities and also potential systemic cytotoxicity. On the other hand, the use of genetic models has had profound implications for our understanding of the molecular regulation of spermatogenesis, and these knockout (null) models have also revealed the factors that are critical for spermatogenesis. Nonetheless, additional studies using in vitro and in vivo models are necessary to unravel the signaling pathways involved in regulating seminiferous epithelial cycle. Emerging data from studies, such as the use of the adjudin pharmaceutical/toxicant model, have illustrated that this non-hormonal male contraceptive drug is utilizing specific signaling pathways/proteins to induce specific defects in spermatogenesis, yielding mechanistic insights on the regulation of spermatogenesis. We sought to review these recent data in this article, highlighting an interesting approach that can be considered for future studies.</p>

mTORC1 Activation Promotes Spermatogonial Differentiation and Causes Subfertility in Mice

Mechanistic target of rapamycin kinase (Mtor) is required for spermatogonial proliferation and differentiation in mice

Mtor/p70s6k Promotes Spermatogonia Proliferation and Spermatogenesis in Sprague Dawley Rats

Mammalian target of rapamycin complex 1 (mTORC1) Is required for mouse spermatogonial differentiation in vivo

Mammalian target of rapamycin is essential for cardiomyocyte survival and heart development in mice.

Rapamycin-mediated mTOR inhibition impairs silencing of sex chromosomes and the pachytene piRNA pathway in the mouse testis

Conditional ablation of Raptor in the male germline causes infertility due to meiotic arrest and impaired inactivation of sex chromosomes

Oocyte stage-specific effects of MTOR determine granulosa cell fate and oocyte quality in mice

Inhibition of mTOR pathway decreases the expression of pre‐meiotic and meiotic markers throughout postnatal development and in adult testes in mice

ClpP/ClpX deficiency impairs mitochondrial functions and mTORC1 signaling during spermatogenesis

Specific Disruption Of Tsc1 In Ovarian Granulosa Cells Promotes Ovulation And Causes Progressive Accumulation Of Corpora Lutea

mTORC1 is required for differentiation of germline stem cells in the Drosophila melanogaster testis

mTOR hypoactivity leads to trophectoderm cell failure by enhancing lysosomal activation and disrupting the cytoskeleton in preimplantation embryo

Androgen Promotes Differentiation of PLZF+ Spermatogonia Pool Via Indirect Regulatory Pattern

mTOR is essential for growth and proliferation in early mouse embryos and embryonic stem cells

mTORC1 Prevents Preosteoblast Differentiation through the Notch Signaling Pathway

mTOR is required for asymmetric division through small GTPases in mouse oocytes

Mtorc1 and Mtorc2 Play Different Roles in Regulating Cardiomyocyte Differentiation from Embryonic Stem Cells.

Rapamycin‐sensitive Mtorc1 Signaling is Involved in Physiological Primordial Follicle Activation in Mouse Ovary

mTORC1/rpS6 and p-FAK-Y407 signaling regulate spermatogenesis: Insights from studies of the adjudin pharmaceutical/toxicant model

An Elaborate Regulation of Mammalian Target of Rapamycin Activity is Required for Somatic Cell Reprogramming Induced by Defined Transcription Factors